Home > > > Report Detail

Covid-19 Impact on Global Transforming Growth Factor Beta 1 Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 29-Apr-2020
No. of pages: 113
Inquire Before Buying

Transforming growth factor beta 1 or TGF-ß1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-ß1 is encoded by the TGFB1 gene

North America is the largest consumption place, with a consumption market share nearly 61.5% In 2018. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Transforming Growth Factor Beta 1 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Transforming Growth Factor Beta 1 3900 industry.

Based on our recent survey, we have several different scenarios about the Transforming Growth Factor Beta 1 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1308.8 million in 2019. The market size of Transforming Growth Factor Beta 1 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transforming Growth Factor Beta 1 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transforming Growth Factor Beta 1 market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Transforming Growth Factor Beta 1 market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Transforming Growth Factor Beta 1 market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Transforming Growth Factor Beta 1 market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Transforming Growth Factor Beta 1 market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transforming Growth Factor Beta 1 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transforming Growth Factor Beta 1 market.

The following manufacturers are covered in this report:

- Roche

- Shionogi Ltd

- Acceleron Pharma Inc

- Genzyme Corp

- Isarna Therapeutics GmbH

- Scholar Rock

- Sirnaomics Inc

- Eli Lilly and Co

- Formation Biologics Inc

- Novartis AG

Transforming Growth Factor Beta 1 Breakdown Data by Type

- Pirfenidone

- Galunisertib

- Others

Transforming Growth Factor Beta 1 Breakdown Data by Application

- IPF

- Cancer

- Others

Covid-19 Impact on Global Transforming Growth Factor Beta 1 Market Size, Status and Forecast 2020-2026

Table of Contents
1 Study Coverage
1.1 Transforming Growth Factor Beta 1 Product Introduction
1.2 Market Segments
1.3 Key Transforming Growth Factor Beta 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type
1.4.2 Pirfenidone
1.4.3 Galunisertib
1.4.4 Others
1.5 Market by Application
1.5.1 Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application
1.5.2 IPF
1.5.3 Cancer
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Transforming Growth Factor Beta 1 Industry Impact
1.6.1 How the Covid-19 is Affecting the Transforming Growth Factor Beta 1 Industry
1.6.1.1 Transforming Growth Factor Beta 1 Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transforming Growth Factor Beta 1 Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transforming Growth Factor Beta 1 Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts
2.1.1 Global Transforming Growth Factor Beta 1 Revenue 2015-2026
2.1.2 Global Transforming Growth Factor Beta 1 Sales 2015-2026
2.2 Transforming Growth Factor Beta 1 Market Size by Region: 2020 Versus 2026
2.2.1 Global Transforming Growth Factor Beta 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Transforming Growth Factor Beta 1 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Transforming Growth Factor Beta 1 Competitor Landscape by Players
3.1 Transforming Growth Factor Beta 1 Sales by Manufacturers
3.1.1 Transforming Growth Factor Beta 1 Sales by Manufacturers (2015-2020)
3.1.2 Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2015-2020)
3.2 Transforming Growth Factor Beta 1 Revenue by Manufacturers
3.2.1 Transforming Growth Factor Beta 1 Revenue by Manufacturers (2015-2020)
3.2.2 Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transforming Growth Factor Beta 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transforming Growth Factor Beta 1 Revenue in 2019
3.2.5 Global Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Transforming Growth Factor Beta 1 Price by Manufacturers
3.4 Transforming Growth Factor Beta 1 Manufacturing Base Distribution, Product Types
3.4.1 Transforming Growth Factor Beta 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transforming Growth Factor Beta 1 Product Type
3.4.3 Date of International Manufacturers Enter into Transforming Growth Factor Beta 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Transforming Growth Factor Beta 1 Market Size by Type (2015-2020)
4.1.1 Global Transforming Growth Factor Beta 1 Sales by Type (2015-2020)
4.1.2 Global Transforming Growth Factor Beta 1 Revenue by Type (2015-2020)
4.1.3 Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transforming Growth Factor Beta 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2021-2026)
4.2.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Type (2021-2026)
4.2.3 Transforming Growth Factor Beta 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transforming Growth Factor Beta 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Transforming Growth Factor Beta 1 Market Size by Application (2015-2020)
5.1.1 Global Transforming Growth Factor Beta 1 Sales by Application (2015-2020)
5.1.2 Global Transforming Growth Factor Beta 1 Revenue by Application (2015-2020)
5.1.3 Transforming Growth Factor Beta 1 Price by Application (2015-2020)
5.2 Transforming Growth Factor Beta 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2021-2026)
5.2.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global Transforming Growth Factor Beta 1 Price Forecast by Application (2021-2026)
6 North America
6.1 North America Transforming Growth Factor Beta 1 by Country
6.1.1 North America Transforming Growth Factor Beta 1 Sales by Country
6.1.2 North America Transforming Growth Factor Beta 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Type
6.3 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Application
7 Europe
7.1 Europe Transforming Growth Factor Beta 1 by Country
7.1.1 Europe Transforming Growth Factor Beta 1 Sales by Country
7.1.2 Europe Transforming Growth Factor Beta 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Type
7.3 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Transforming Growth Factor Beta 1 by Region
8.1.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Region
8.1.2 Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Type
8.3 Asia Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Application
9 Latin America
9.1 Latin America Transforming Growth Factor Beta 1 by Country
9.1.1 Latin America Transforming Growth Factor Beta 1 Sales by Country
9.1.2 Latin America Transforming Growth Factor Beta 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Transforming Growth Factor Beta 1 Market Facts & Figures by Type
9.3 Central & South America Transforming Growth Factor Beta 1 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Transforming Growth Factor Beta 1 by Country
10.1.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country
10.1.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Type
10.3 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Transforming Growth Factor Beta 1 Products Offered
11.1.5 Roche Recent Development
11.2 Shionogi Ltd
11.2.1 Shionogi Ltd Corporation Information
11.2.2 Shionogi Ltd Description, Business Overview and Total Revenue
11.2.3 Shionogi Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Shionogi Ltd Transforming Growth Factor Beta 1 Products Offered
11.2.5 Shionogi Ltd Recent Development
11.3 Acceleron Pharma Inc
11.3.1 Acceleron Pharma Inc Corporation Information
11.3.2 Acceleron Pharma Inc Description, Business Overview and Total Revenue
11.3.3 Acceleron Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Products Offered
11.3.5 Acceleron Pharma Inc Recent Development
11.4 Genzyme Corp
11.4.1 Genzyme Corp Corporation Information
11.4.2 Genzyme Corp Description, Business Overview and Total Revenue
11.4.3 Genzyme Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Genzyme Corp Transforming Growth Factor Beta 1 Products Offered
11.4.5 Genzyme Corp Recent Development
11.5 Isarna Therapeutics GmbH
11.5.1 Isarna Therapeutics GmbH Corporation Information
11.5.2 Isarna Therapeutics GmbH Description, Business Overview and Total Revenue
11.5.3 Isarna Therapeutics GmbH Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Products Offered
11.5.5 Isarna Therapeutics GmbH Recent Development
11.6 Scholar Rock
11.6.1 Scholar Rock Corporation Information
11.6.2 Scholar Rock Description, Business Overview and Total Revenue
11.6.3 Scholar Rock Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Scholar Rock Transforming Growth Factor Beta 1 Products Offered
11.6.5 Scholar Rock Recent Development
11.7 Sirnaomics Inc
11.7.1 Sirnaomics Inc Corporation Information
11.7.2 Sirnaomics Inc Description, Business Overview and Total Revenue
11.7.3 Sirnaomics Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sirnaomics Inc Transforming Growth Factor Beta 1 Products Offered
11.7.5 Sirnaomics Inc Recent Development
11.8 Eli Lilly and Co
11.8.1 Eli Lilly and Co Corporation Information
11.8.2 Eli Lilly and Co Description, Business Overview and Total Revenue
11.8.3 Eli Lilly and Co Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Eli Lilly and Co Transforming Growth Factor Beta 1 Products Offered
11.8.5 Eli Lilly and Co Recent Development
11.9 Formation Biologics Inc
11.9.1 Formation Biologics Inc Corporation Information
11.9.2 Formation Biologics Inc Description, Business Overview and Total Revenue
11.9.3 Formation Biologics Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Formation Biologics Inc Transforming Growth Factor Beta 1 Products Offered
11.9.5 Formation Biologics Inc Recent Development
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Description, Business Overview and Total Revenue
11.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis AG Transforming Growth Factor Beta 1 Products Offered
11.10.5 Novartis AG Recent Development
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description, Business Overview and Total Revenue
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Transforming Growth Factor Beta 1 Products Offered
11.1.5 Roche Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Transforming Growth Factor Beta 1 Market Estimates and Projections by Region
12.1.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Regions 2021-2026
12.1.2 Global Transforming Growth Factor Beta 1 Revenue Forecast by Regions 2021-2026
12.2 North America Transforming Growth Factor Beta 1 Market Size Forecast (2021-2026)
12.2.1 North America: Transforming Growth Factor Beta 1 Sales Forecast (2021-2026)
12.2.2 North America: Transforming Growth Factor Beta 1 Revenue Forecast (2021-2026)
12.2.3 North America: Transforming Growth Factor Beta 1 Market Size Forecast by Country (2021-2026)
12.3 Europe Transforming Growth Factor Beta 1 Market Size Forecast (2021-2026)
12.3.1 Europe: Transforming Growth Factor Beta 1 Sales Forecast (2021-2026)
12.3.2 Europe: Transforming Growth Factor Beta 1 Revenue Forecast (2021-2026)
12.3.3 Europe: Transforming Growth Factor Beta 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Transforming Growth Factor Beta 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Transforming Growth Factor Beta 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Transforming Growth Factor Beta 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Transforming Growth Factor Beta 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America Transforming Growth Factor Beta 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: Transforming Growth Factor Beta 1 Sales Forecast (2021-2026)
12.5.2 Latin America: Transforming Growth Factor Beta 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: Transforming Growth Factor Beta 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Transforming Growth Factor Beta 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Transforming Growth Factor Beta 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Transforming Growth Factor Beta 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Transforming Growth Factor Beta 1 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Transforming Growth Factor Beta 1 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transforming Growth Factor Beta 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Transforming Growth Factor Beta 1 Market Segments
Table 2. Ranking of Global Top Transforming Growth Factor Beta 1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Pirfenidone
Table 5. Major Manufacturers of Galunisertib
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Transforming Growth Factor Beta 1 Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Transforming Growth Factor Beta 1 Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Transforming Growth Factor Beta 1 Players to Combat Covid-19 Impact
Table 12. Global Transforming Growth Factor Beta 1 Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Transforming Growth Factor Beta 1 Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Transforming Growth Factor Beta 1 Sales by Regions 2015-2020 (K Units)
Table 15. Global Transforming Growth Factor Beta 1 Sales Market Share by Regions (2015-2020)
Table 16. Global Transforming Growth Factor Beta 1 Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Transforming Growth Factor Beta 1 Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Transforming Growth Factor Beta 1 Sales Share by Manufacturers (2015-2020)
Table 19. Global Transforming Growth Factor Beta 1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Transforming Growth Factor Beta 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transforming Growth Factor Beta 1 as of 2019)
Table 21. Transforming Growth Factor Beta 1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Transforming Growth Factor Beta 1 Price (2015-2020) (USD/Unit)
Table 24. Transforming Growth Factor Beta 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Transforming Growth Factor Beta 1 Product Type
Table 26. Date of International Manufacturers Enter into Transforming Growth Factor Beta 1 Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Transforming Growth Factor Beta 1 Sales by Type (2015-2020) (K Units)
Table 29. Global Transforming Growth Factor Beta 1 Sales Share by Type (2015-2020)
Table 30. Global Transforming Growth Factor Beta 1 Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Transforming Growth Factor Beta 1 Revenue Share by Type (2015-2020)
Table 32. Transforming Growth Factor Beta 1 Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Transforming Growth Factor Beta 1 Sales by Application (2015-2020) (K Units)
Table 34. Global Transforming Growth Factor Beta 1 Sales Share by Application (2015-2020)
Table 35. North America Transforming Growth Factor Beta 1 Sales by Country (2015-2020) (K Units)
Table 36. North America Transforming Growth Factor Beta 1 Sales Market Share by Country (2015-2020)
Table 37. North America Transforming Growth Factor Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2015-2020)
Table 39. North America Transforming Growth Factor Beta 1 Sales by Type (2015-2020) (K Units)
Table 40. North America Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
Table 41. North America Transforming Growth Factor Beta 1 Sales by Application (2015-2020) (K Units)
Table 42. North America Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
Table 43. Europe Transforming Growth Factor Beta 1 Sales by Country (2015-2020) (K Units)
Table 44. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2015-2020)
Table 45. Europe Transforming Growth Factor Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2015-2020)
Table 47. Europe Transforming Growth Factor Beta 1 Sales by Type (2015-2020) (K Units)
Table 48. Europe Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
Table 49. Europe Transforming Growth Factor Beta 1 Sales by Application (2015-2020) (K Units)
Table 50. Europe Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Transforming Growth Factor Beta 1 Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Transforming Growth Factor Beta 1 Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
Table 59. Latin America Transforming Growth Factor Beta 1 Sales by Country (2015-2020) (K Units)
Table 60. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Transforming Growth Factor Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2015-2020)
Table 63. Latin America Transforming Growth Factor Beta 1 Sales by Type (2015-2020) (K Units)
Table 64. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
Table 65. Latin America Transforming Growth Factor Beta 1 Sales by Application (2015-2020) (K Units)
Table 66. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
Table 75. Roche Corporation Information
Table 76. Roche Description and Major Businesses
Table 77. Roche Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Roche Product
Table 79. Roche Recent Development
Table 80. Shionogi Ltd Corporation Information
Table 81. Shionogi Ltd Description and Major Businesses
Table 82. Shionogi Ltd Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Shionogi Ltd Product
Table 84. Shionogi Ltd Recent Development
Table 85. Acceleron Pharma Inc Corporation Information
Table 86. Acceleron Pharma Inc Description and Major Businesses
Table 87. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Acceleron Pharma Inc Product
Table 89. Acceleron Pharma Inc Recent Development
Table 90. Genzyme Corp Corporation Information
Table 91. Genzyme Corp Description and Major Businesses
Table 92. Genzyme Corp Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Genzyme Corp Product
Table 94. Genzyme Corp Recent Development
Table 95. Isarna Therapeutics GmbH Corporation Information
Table 96. Isarna Therapeutics GmbH Description and Major Businesses
Table 97. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Isarna Therapeutics GmbH Product
Table 99. Isarna Therapeutics GmbH Recent Development
Table 100. Scholar Rock Corporation Information
Table 101. Scholar Rock Description and Major Businesses
Table 102. Scholar Rock Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Scholar Rock Product
Table 104. Scholar Rock Recent Development
Table 105. Sirnaomics Inc Corporation Information
Table 106. Sirnaomics Inc Description and Major Businesses
Table 107. Sirnaomics Inc Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Sirnaomics Inc Product
Table 109. Sirnaomics Inc Recent Development
Table 110. Eli Lilly and Co Corporation Information
Table 111. Eli Lilly and Co Description and Major Businesses
Table 112. Eli Lilly and Co Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Eli Lilly and Co Product
Table 114. Eli Lilly and Co Recent Development
Table 115. Formation Biologics Inc Corporation Information
Table 116. Formation Biologics Inc Description and Major Businesses
Table 117. Formation Biologics Inc Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Formation Biologics Inc Product
Table 119. Formation Biologics Inc Recent Development
Table 120. Novartis AG Corporation Information
Table 121. Novartis AG Description and Major Businesses
Table 122. Novartis AG Transforming Growth Factor Beta 1 Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Novartis AG Product
Table 124. Novartis AG Recent Development
Table 125. Global Transforming Growth Factor Beta 1 Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Transforming Growth Factor Beta 1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Transforming Growth Factor Beta 1 Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Transforming Growth Factor Beta 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Transforming Growth Factor Beta 1 Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Transforming Growth Factor Beta 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Transforming Growth Factor Beta 1 Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Transforming Growth Factor Beta 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Transforming Growth Factor Beta 1 Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Transforming Growth Factor Beta 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Transforming Growth Factor Beta 1 Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Transforming Growth Factor Beta 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Transforming Growth Factor Beta 1 Players
Table 143. Transforming Growth Factor Beta 1 Customers List
Table 144. Transforming Growth Factor Beta 1 Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Transforming Growth Factor Beta 1 Product Picture
Figure 2. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2020 & 2026
Figure 3. Pirfenidone Product Picture
Figure 4. Galunisertib Product Picture
Figure 5. Others Product Picture
Figure 6. Global Transforming Growth Factor Beta 1 Sales Market Share by Application in 2020 & 2026
Figure 7. IPF
Figure 8. Cancer
Figure 9. Others
Figure 10. Transforming Growth Factor Beta 1 Report Years Considered
Figure 11. Global Transforming Growth Factor Beta 1 Market Size 2015-2026 (US$ Million)
Figure 12. Global Transforming Growth Factor Beta 1 Sales 2015-2026 (K Units)
Figure 13. Global Transforming Growth Factor Beta 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2015-2020)
Figure 15. Global Transforming Growth Factor Beta 1 Sales Market Share by Region in 2019
Figure 16. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2015-2020)
Figure 17. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region in 2019
Figure 18. Global Transforming Growth Factor Beta 1 Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Transforming Growth Factor Beta 1 Revenue in 2019
Figure 20. Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
Figure 22. Global Transforming Growth Factor Beta 1 Sales Market Share by Type in 2019
Figure 23. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2015-2020)
Figure 24. Global Transforming Growth Factor Beta 1 Revenue Market Share by Type in 2019
Figure 25. Global Transforming Growth Factor Beta 1 Market Share by Price Range (2015-2020)
Figure 26. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
Figure 27. Global Transforming Growth Factor Beta 1 Sales Market Share by Application in 2019
Figure 28. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2015-2020)
Figure 29. Global Transforming Growth Factor Beta 1 Revenue Market Share by Application in 2019
Figure 30. North America Transforming Growth Factor Beta 1 Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Transforming Growth Factor Beta 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Transforming Growth Factor Beta 1 Sales Market Share by Country in 2019
Figure 33. North America Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2019
Figure 34. U.S. Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Transforming Growth Factor Beta 1 Market Share by Type in 2019
Figure 39. North America Transforming Growth Factor Beta 1 Market Share by Application in 2019
Figure 40. Europe Transforming Growth Factor Beta 1 Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Transforming Growth Factor Beta 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country in 2019
Figure 43. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2019
Figure 44. Germany Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Transforming Growth Factor Beta 1 Market Share by Type in 2019
Figure 55. Europe Transforming Growth Factor Beta 1 Market Share by Application in 2019
Figure 56. Asia Pacific Transforming Growth Factor Beta 1 Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Transforming Growth Factor Beta 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Region in 2019
Figure 59. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Region in 2019
Figure 60. China Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia T
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs